De novo malignancies after adult-to-adult living-donor liver transplantation with a malignancy surveillance program: Comparison with a japanese population-based study

Transplantation

Volumn 95, Issue 9, 2013, Pages 1142-1147

  Kaneko, Junichi ^a   Sugawara, Yasuhiko ^a   Tamura, Sumihito ^a   Aoki, Taku ^a   Sakamoto, Yoshihiro ^a   Hasegawa, Kiyoshi ^a   Yamashiki, Noriyo ^a   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

De novo malignancy; Japanese; Liver transplantation; Living donor

Indexed keywords

METHYLPREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOID; CHRONIC GRAFT REJECTION; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; ESOPHAGUS CANCER; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEPATITIS B; HEPATITIS C; HUMAN; JAPANESE; KIDNEY CARCINOMA; LEUKEMIA; LIVER CANCER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; POPULATION RESEARCH; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; STOMACH CANCER; SURVIVAL RATE;

ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; LIVING DONORS; PROGNOSIS; SURVIVAL RATE;

EID: 84877576126     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318288ca83     Document Type: Article

References (37)

1. Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343: 1233.
2. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147.
3. Vogt DP, Henderson JM, Carey WD, et al. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002; 132: 775.
4. Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant 2010; 10: 1889.
5. Herrero JI. De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl 2009; 15: S90.
6. Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med 2006; 166: 1907.
7. Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2012; 42: 139.
8. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
9. Sugawara Y, Makuuchi M, Takayama T, et al. Safe donor hepatectomy for living related liver transplantation. Liver Transpl 2002;8:58.
10. Sugawara Y, Makuuchi M, Sano K, et al. Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg 2003; 237: 180.
11. Sugawara Y, Tamura S, Kaneko J, et al. Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation. Dig Surg 2009; 26: 482.
12. Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leukoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 1997; 99: 222.
13. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31: 792.
14. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658.
15. Kazama S, Hongo K, Sunami E, et al. Six cases of primary colorectal cancer after living-donor liver transplantation: a single-institution experience in Japan. Jpn J Clin Oncol 2012; 42: 586.
16. Kataoka K, Seo S, Sugawara Y, et al. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature. Leuk Lymphoma 2010; 51: 1494.
17. Hashimoto T, Sugawara Y, Kishi Y, et al. Long-term survival and causes of late graft loss after adult-to-adult living donor liver transplantation. Transplant Proc 2005; 37: 4383.
18. Herrero JI, Lorenzo M, Quiroga J, et al. De novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transpl 2005; 11:89.
19. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34:84.
20. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving 9 or = 5 years after liver transplant. Transplantation 2000; 69: 781.
21. Oo YH, Gunson BK, Lancashire RJ, et al. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005; 80: 759.
22. Aberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008; 14: 1428.
23. Ministry of Health, Labour and Welfare of Japan. Available at: http://www.mhlw.go.jp/shingi/2008/03/s0301-4.html. Accessed December 13, 2012.
24. Schober T, Framke T, Kreipe H, et al. Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Transplantation 2013; 95: 240.
25. Dreno B, Mansat E, Legoux B, et al. Skin cancers in transplant patients. Nephrol Dial Transplant 1998; 13: 1374.
26. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122: 1288.
27. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
28. Park HW, Hwang S, Ahn CS, et al. De novo malignancies after liver transplantation: incidence comparison with the Korean cancer registry. Transplant Proc 2012; 44: 802.
29. Ishikawa N, Tanabe K, Tokumoto T, et al. Clinical study of malignancies after renal transplantation and impact of routine screening for early detection: a single-center experience. Transplant Proc 2000; 32: 1907.
30. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990; 323: 1767.
31. Harwood CA, Mesher D,McGregor JM, et al. A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant 2013; 13: 119.
32. Herrero JI. Screening of de novo tumors after liver transplantation. J Gastroenterol Hepatol 2012; 27: 1011.
33. Fung JJ, Jain A, Kwak EJ, et al. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001; 7: S109.
34. Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005; 56:87.
35. SilvaMA, JambulingamPS, Mirza DF. Colorectal cancer after orthotopic liver transplantation. Crit Rev Oncol Hematol 2005; 56: 147.
36. Sint Nicolaas J, de Jonge V, Steyerberg EW, et al. Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010; 10: 868.
37. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003; 75: 1983.